• Latest Posts

Ghana becomes first country to approve University of Oxford malaria vaccine

Fight against malaria boosted by findings from a vaccine trial showing high efficacy

Oxford Science Enterprises raises £250M

EMA Green Light Sends Oxford Covid-19 Vaccine Into Turbulent Market

AstraZeneca’s Covid-19 Vaccine Proves Its Worth in Phase III

More News! 7 Oct 2019

UK Biotech Launches with €30M Series A to Treat Autoimmune Disease

Organs-on-a-Chip for Drug Research in a Range of Diseases Make it to the Market

€40M in Series C for a British Biotech Treating Blindness with Gene Therapy

LAB282 Awards Second Funding Round to 5 Academic Projects at Oxford

New Dutch Biotech Gets Funding to Find Genetic Off Switches

New Grant to Advance a Whole New Treatment Against Parkinson’s in the UK